Grifols, S.A. (GIFLF) Financials

GIFLF Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 23.1 billion 14.2 billion
Sept. 30, 2025 23.3 billion 14.4 billion
June 30, 2025 23.3 billion 14.3 billion
March 31, 2025 22.7 billion 13.7 billion

GIFLF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
Sept. 30, 2025 299.7 million ?
June 30, 2025 112.0 million ?
March 31, 2025 93.4 million ?

GIFLF Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 ?
Sept. 30, 2025 149.0 million
June 30, 2025 138.0 million
March 31, 2025 64.6 million

GIFLF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 968.7 million 10.7 billion -
Sept. 30, 2025 968.7 million 1.1 billion 1.3 billion
June 30, 2025 666.9 million 9.9 billion 1.3 billion
March 31, 2025 1.1 billion 10.2 billion -

GIFLF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 ?
Sept. 30, 2025 ?
June 30, 2025 801.2 million
March 31, 2025 ?

GIFLF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 160.5 million 323.1 million -
Sept. 30, 2025 82.2 million 113.9 million 321.3 million -
June 30, 2025 71.0 million 113.4 million 333.3 million -
March 31, 2025 53.2 million 103.9 million 341.2 million -

GIFLF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 2.3 billion 1.5 billion
Sept. 30, 2025 2.2 billion 1.3 billion
June 30, 2025 2.2 billion 1.4 billion
March 31, 2025 1.9 billion 1.2 billion

GIFLF

Price: $12.90

52 week price:
8.40
14.00

Dividend Yield: 1.54%

Payout Ratio Range:
0.00%
182.18%

Earnings Per Share: 0.65 USD

P/E Ratio: 17.94

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 7.9 billion

Links: